KATRINA SMITH: Open Payments
NPI 1316665342 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 10 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $118 · 2025 $1,118
Food & beverage: $1,118
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $252 |
| Smith+Nephew, Inc. | 1 | $148 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| ABBVIE INC. | 1 | $118 |
| Averitas Pharma Inc. | 1 | $113 |
| Novo Nordisk Inc | 1 | $112 |
| Otsuka America Pharmaceutical, Inc. | 1 | $107 |
| Calliditas Therapeutics US Inc. | 1 | $26 |
Products named: TC-100, WAINUA, AIRSUPRA, AUSTEDO XR, Auvelity, VENCLEXTA, QUTENZA, Ozempic.
Industry payments across KS — which companies pay providers there.
